Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
AVM Biotechnology Inc
BeOne Medicines
Nurix Therapeutics, Inc.
Verismo Therapeutics
Janssen Research & Development, LLC
AstraZeneca
Adicet Therapeutics
Gilead Sciences
AstraZeneca
Novartis
Vironexis Biotherapeutics Inc.
AbbVie
AstraZeneca
Nurix Therapeutics, Inc.